News
MedPage Today on MSN18h
Adding Neoadjuvant Nivolumab to Chemo Improved Survival in Resectable NSCLCNeoadjuvant nivolumab (Opdivo) plus chemotherapy significantly improved overall survival (OS) compared with chemotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback